Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BLI5100 in Erosive Esophagitis
NCT05587309Phase 3Completed
- Sponsor
- Braintree Laboratories
- Start
- Oct 2022
- Primary completion
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of tegoprazan in erosive esophagitis (EE), sponsored by Braintree Laboratories. Started Oct 2022; status: completed.
02
Drugs
tegoprazan
03
Conditions
erosive esophagitis (EE)
Beyond the preview
Go deeper on NCT05587309.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05587309.